227 related articles for article (PubMed ID: 31386928)
1. Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism.
Sun Y; Lv X; Ding P; Wang L; Sun Y; Li S; Zhang H; Gao Z
Acta Biomater; 2019 Oct; 97():93-104. PubMed ID: 31386928
[TBL] [Abstract][Full Text] [Related]
2. Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.
Kreppel F; Kochanek S
Mol Ther; 2008 Jan; 16(1):16-29. PubMed ID: 17912234
[TBL] [Abstract][Full Text] [Related]
3. Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.
Yoon AR; Hong J; Kim SW; Yun CO
Expert Opin Drug Deliv; 2016 Jun; 13(6):843-58. PubMed ID: 26967319
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.
Kim J; Kim PH; Kim SW; Yun CO
Biomaterials; 2012 Feb; 33(6):1838-50. PubMed ID: 22142769
[TBL] [Abstract][Full Text] [Related]
5. PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability.
Eto Y; Gao JQ; Sekiguchi F; Kurachi S; Katayama K; Maeda M; Kawasaki K; Mizuguchi H; Hayakawa T; Tsutsumi Y; Mayumi T; Nakagawa S
J Gene Med; 2005 May; 7(5):604-12. PubMed ID: 15543536
[TBL] [Abstract][Full Text] [Related]
6. Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction.
Descamps D; Benihoud K
Curr Gene Ther; 2009 Apr; 9(2):115-27. PubMed ID: 19355869
[TBL] [Abstract][Full Text] [Related]
7. Tuning Surface Charge and PEGylation of Biocompatible Polymers for Efficient Delivery of Nucleic Acid or Adenoviral Vector.
Choi JW; Kim J; Bui QN; Li Y; Yun CO; Lee DS; Kim SW
Bioconjug Chem; 2015 Aug; 26(8):1818-29. PubMed ID: 26158495
[TBL] [Abstract][Full Text] [Related]
8. Targeted adenovirus vectors.
Mizuguchi H; Hayakawa T
Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
[TBL] [Abstract][Full Text] [Related]
9. Polymeric oncolytic adenovirus for cancer gene therapy.
Choi JW; Lee YS; Yun CO; Kim SW
J Control Release; 2015 Dec; 219():181-191. PubMed ID: 26453806
[TBL] [Abstract][Full Text] [Related]
10. Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer.
Kim J; Nam HY; Choi JW; Yun CO; Kim SW
Gene Ther; 2014 May; 21(5):476-83. PubMed ID: 24598892
[TBL] [Abstract][Full Text] [Related]
11. Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.
Einfeld DA; Schroeder R; Roelvink PW; Lizonova A; King CR; Kovesdi I; Wickham TJ
J Virol; 2001 Dec; 75(23):11284-91. PubMed ID: 11689608
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus receptors and their implications in gene delivery.
Sharma A; Li X; Bangari DS; Mittal SK
Virus Res; 2009 Aug; 143(2):184-94. PubMed ID: 19647886
[TBL] [Abstract][Full Text] [Related]
13. pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.
Choi JW; Jung SJ; Kasala D; Hwang JK; Hu J; Bae YH; Yun CO
J Control Release; 2015 May; 205():134-43. PubMed ID: 25575865
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.
Mok H; Palmer DJ; Ng P; Barry MA
Mol Ther; 2005 Jan; 11(1):66-79. PubMed ID: 15585407
[TBL] [Abstract][Full Text] [Related]
15. Optimizing Active Tumor Targeting Biocompatible Polymers for Efficient Systemic Delivery of Adenovirus.
Lee JY; Hong JW; Thambi T; Yoon AR; Choi JW; Li Y; Bui QN; Lee DS; Yun CO
Cells; 2021 Jul; 10(8):. PubMed ID: 34440666
[TBL] [Abstract][Full Text] [Related]
16. Development of PEGylated adenovirus vector with targeting ligand.
Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in oncolytic adenovirus therapies for cancer.
Rosewell Shaw A; Suzuki M
Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906
[TBL] [Abstract][Full Text] [Related]
18. The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy.
Kim PH; Kim TI; Yockman JW; Kim SW; Yun CO
Biomaterials; 2010 Mar; 31(7):1865-74. PubMed ID: 19962189
[TBL] [Abstract][Full Text] [Related]
19. Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus.
Moon CY; Choi JW; Kasala D; Jung SJ; Kim SW; Yun CO
Biomaterials; 2015 Feb; 41():53-68. PubMed ID: 25522965
[TBL] [Abstract][Full Text] [Related]
20. Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies.
Wortmann A; Vöhringer S; Engler T; Corjon S; Schirmbeck R; Reimann J; Kochanek S; Kreppel F
Mol Ther; 2008 Jan; 16(1):154-62. PubMed ID: 17848961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
